Martin Shkreli on prison, beating Bloomberg, and being hated
Feb 11, 2026•1 hr 2 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Martin Shkreli is the co-founder of DL Software, the parent company of Godel Terminal, a Bloomberg competitor for financial data. He previously founded the biotech companies Retrophin and Turing Pharmaceuticals and the hedge fund MSMB Capital Management.
In this episode of Summation, Martin and Auren discuss:
- The structural reasons fintech is less competitive than other industries
- How drug discovery actually works (and doing it from prison)
- Why AI labs are now out-recruiting hedge funds
- What Martin learned from being "the most hated man in America"
You can find Auren Hoffman on X at @auren and Martin Shkreli on X at @MartinShkreli
For the best experience, listen in Metacast app for iOS or Android